Proteomic analysis of pulmonary arteries and lung tissues from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0296068 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Siriwan Sakarin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Pulmonary Artery, Hypertension, Pulmonary. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the 90th Anniversary of Chulalongkorn University Fund, the 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship.
Abstract (Originalsprache)
In dogs with degenerative mitral valve disease (DMVD), pulmonary hypertension (PH) is a common complication characterized by abnormally elevated pulmonary arterial pressure (PAP). Pulmonary arterial remodeling is the histopathological changes of pulmonary artery that has been recognized in PH. The underlying mechanisms that cause this arterial remodeling are poorly understood. This study aimed to perform shotgun proteomics to investigate changes in protein expression in pulmonary arteries and lung tissues of DMVD dogs with PH compared to normal control dogs and DMVD dogs without PH. Tissue samples were collected from the carcasses of 22 small-sized breed dogs and divided into three groups: control (n = 7), DMVD (n = 7) and DMVD+PH groups (n = 8). Differentially expressed proteins were identified, and top three upregulated and downregulated proteins in the pulmonary arteries of DMVD dogs with PH including SIK family kinase 3 (SIK3), Collagen type I alpha 1 chain (COL1A1), Transforming growth factor alpha (TGF-α), Apoptosis associated tyrosine kinase (AATYK), Hepatocyte growth factor activator (HGFA) and Tyrosine-protein phosphatase non-receptor type 13 (PTPN13) were chosen. Results showed that some of the identified proteins may play a role in the pathogenesis of pulmonary arterial remodeling. This study concluded shotgun proteomics has potential as a tool for exploring candidate proteins associated with the pathogenesis of PH secondary to DMVD in dogs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Veterinary Medicine, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand.
- Center of Excellence for Companion Animal Cancer, Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand.
- Functional Proteomics Technology Laboratory, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Pathum Thani, Thailand.
ORCID-Profile: Sirilak Disatian Surachetpong
Förderung
- the 90th Anniversary of Chulalongkorn University Fund
- the 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship
Zitieren
APA
Sakarin, S., Rungsipipat, A., Roytrakul, S., Jaresitthikunchai, J., Phaonakrop, N., Charoenlappanit, S., Thaisakun, S., & Surachetpong, S. D. (2024). Proteomic analysis of pulmonary arteries and lung tissues from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease. PLOS ONE. https://doi.org/10.1371/journal.pone.0296068
Vancouver
Sakarin S, Rungsipipat A, Roytrakul S, Jaresitthikunchai J, Phaonakrop N, Charoenlappanit S, et al. Proteomic analysis of pulmonary arteries and lung tissues from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease. PLOS ONE. 2024. doi:10.1371/journal.pone.0296068
BibTeX
@article{Sakarin2024,
author = {Sakarin, Siriwan and Rungsipipat, Anudep and Roytrakul, Sittiruk and Jaresitthikunchai, Janthima and Phaonakrop, Narumon and Charoenlappanit, Sawanya and Thaisakun, Siriwan and Surachetpong, Sirilak Disatian},
title = {Proteomic analysis of pulmonary arteries and lung tissues from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0296068}
}
EUVIMED